273 related articles for article (PubMed ID: 16177809)
1. Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection.
Liu XS; Zhang ZG; Zhang L; Morris DC; Kapke A; Lu M; Chopp M
J Cereb Blood Flow Metab; 2006 Jun; 26(6):787-96. PubMed ID: 16177809
[TBL] [Abstract][Full Text] [Related]
2. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability.
Cui L; Zhang X; Yang R; Wang L; Liu L; Li M; Du W
Brain Res; 2010 Apr; 1325():164-73. PubMed ID: 20167207
[TBL] [Abstract][Full Text] [Related]
4. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
Zhang L; Zhang ZG; Liu X; Hozeska A; Stagliano N; Riordan W; Lu M; Chopp M
Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976
[TBL] [Abstract][Full Text] [Related]
5. Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke.
Guo M; Cox B; Mahale S; Davis W; Carranza A; Hayes K; Sprague S; Jimenez D; Ding Y
Neuroscience; 2008 Jan; 151(2):340-51. PubMed ID: 18160227
[TBL] [Abstract][Full Text] [Related]
6. The PI3K/Akt pathway mediates the neuroprotective effect of atorvastatin in extending thrombolytic therapy after embolic stroke in the rat.
Zhang L; Zhang ZG; Liu XS; Hozeska-Solgot A; Chopp M
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2470-5. PubMed ID: 17717296
[TBL] [Abstract][Full Text] [Related]
7. Potentiating effect of endothelial cells on astrocytic plasminogen activator inhibitor type-1 gene expression in an in vitro model of the blood-brain barrier.
Hultman K; Björklund U; Hansson E; Jern C
Neuroscience; 2010 Mar; 166(2):408-15. PubMed ID: 20060032
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.
Wang X; Lee SR; Arai K; Lee SR; Tsuji K; Rebeck GW; Lo EH
Nat Med; 2003 Oct; 9(10):1313-7. PubMed ID: 12960961
[TBL] [Abstract][Full Text] [Related]
9. Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia.
Chang DI; Hosomi N; Lucero J; Heo JH; Abumiya T; Mazar AP; del Zoppo GJ
J Cereb Blood Flow Metab; 2003 Dec; 23(12):1408-19. PubMed ID: 14663336
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model.
Maeda M; Furuichi Y; Noto T; Matsuoka N; Mutoh S; Yoneda Y
Brain Res; 2009 Feb; 1254():99-108. PubMed ID: 19101526
[TBL] [Abstract][Full Text] [Related]
11. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B
Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
[TBL] [Abstract][Full Text] [Related]
12. Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus.
Riad A; Du J; Stiehl S; Westermann D; Mohr Z; Sobirey M; Doehner W; Adams V; Pauschinger M; Schultheiss HP; Tschöpe C
Eur J Pharmacol; 2007 Aug; 569(3):204-11. PubMed ID: 17669395
[TBL] [Abstract][Full Text] [Related]
13. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
[TBL] [Abstract][Full Text] [Related]
14. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y
Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949
[TBL] [Abstract][Full Text] [Related]
16. MRI of combination treatment of embolic stroke in rat with rtPA and atorvastatin.
Ding G; Jiang Q; Li L; Zhang L; Zhang ZG; Panda S; Ewing JR; Chopp M
J Neurol Sci; 2006 Jul; 246(1-2):139-47. PubMed ID: 16626754
[TBL] [Abstract][Full Text] [Related]
17. Chronic nicotine treatment enhances focal ischemic brain injury and depletes free pool of brain microvascular tissue plasminogen activator in rats.
Wang L; Kittaka M; Sun N; Schreiber SS; Zlokovic BV
J Cereb Blood Flow Metab; 1997 Feb; 17(2):136-46. PubMed ID: 9040492
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9.
Souza-Costa DC; Figueiredo-Lopes L; Alves-Filho JC; Semprini MC; Gerlach RF; Cunha FQ; Tanus-Santos JE
Crit Care Med; 2007 Jan; 35(1):239-45. PubMed ID: 17133179
[TBL] [Abstract][Full Text] [Related]
19. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
[TBL] [Abstract][Full Text] [Related]
20. Astrocyte regulation of endothelial tissue plasminogen activator in a blood-brain barrier model.
Tran ND; Schreiber SS; Fisher M
J Cereb Blood Flow Metab; 1998 Dec; 18(12):1316-24. PubMed ID: 9850144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
